Actieve functies van Guy Debruyne
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Blue Star Invest SA | Algemeen Directeur | - | - |
CG Cube SA | Directeur/Bestuurslid | - | - |
Le Bocholtz SA | Directeur/Bestuurslid | - | - |
Mithra Pharmaceuticals CDMO SA
Mithra Pharmaceuticals CDMO SA Pharmaceuticals: MajorHealth Technology Part of Mithra Pharmaceuticals SA, Mithra Pharmaceuticals CDMO SA is a Belgian biotech company that focuses on transforming women's health through innovation. The company is based in Liege, Belgium and has a global presence in over 100 countries with a staff count of approximately 300. Mithra CDMO is an integrated research, development, and manufacturing platform that takes products from proof of concept to market. The company's current research and development pipeline includes two products based on the novel natural estrogen, estetrol (e4), as well as three complex therapeutics. The company was founded in 2013, and the CEO is François Fornieri. | Directeur/Bestuurslid | - | - |
Loopbaan van Guy Debruyne
Eerdere bekende functies van Guy Debruyne
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MITHRA PHARMACEUTICALS S.A. | Directeur/Bestuurslid | 14-07-2011 | - |
Statistieken
Internationaal
België | 4 |
Luxemburg | 3 |
Operationeel
Director/Board Member | 4 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MITHRA PHARMACEUTICALS S.A. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Le Bocholtz SA | |
Mithra Pharmaceuticals CDMO SA
Mithra Pharmaceuticals CDMO SA Pharmaceuticals: MajorHealth Technology Part of Mithra Pharmaceuticals SA, Mithra Pharmaceuticals CDMO SA is a Belgian biotech company that focuses on transforming women's health through innovation. The company is based in Liege, Belgium and has a global presence in over 100 countries with a staff count of approximately 300. Mithra CDMO is an integrated research, development, and manufacturing platform that takes products from proof of concept to market. The company's current research and development pipeline includes two products based on the novel natural estrogen, estetrol (e4), as well as three complex therapeutics. The company was founded in 2013, and the CEO is François Fornieri. | Health Technology |
Blue Star Invest SA | |
CG Cube SA |
- Beurs
- Insiders
- Guy Debruyne
- Ervaring